Pig & Poultry Vaccines

Multivalent inactivated vaccine for egg laying hens. Target species Chickens (breeders and layers) Indications for use For the vaccination of layer and breeder birds to: • Reduction of infection and prevention of egg drop caused by the Massachusetts serotype of Infectious Bronchitis Virus; • Reduction of egg drop and egg shell defects caused by the D274/D207 serotype of Infectious Bronchitis Virus; • Reduction of infection caused by Newcastle Disease Virus; • Prevention of respiratory signs and reduction of egg drop and egg shell defects related to Avian Rhinotracheitis virus (avian pneumovirus); • Reduction of egg drop and egg shell defects related to EDS’76 virus Withdrawal periods Zero days

For active immunisation of breeding pigs (sows, gilts and boars) against porcine parvovirosis, to reduce the number of still births and mummified piglets, and against erysipelas to reduce or prevent clinical symptoms.

Porcilis APP contains toxoids produced by Actinobacillus pleuropneumoniae and can be used to immunise pigs against pleuropneumonia. Its use may contribute to the reduction of antimicrobial use. Target species Pigs Indications for use Porcilis APP is for the active immunisation of weaned piglets to reduce mortality, clinical signs and lesions of pleuropneumonia caused by Actinobacillus pleuropneumoniae. Onset of immunity: 2 weeks after completion of the vaccination scheme. Duration of immunity: 11 weeks after completion of the vaccination scheme. Withdrawal periods Pigs – meat 0 days

Porcilis AR -T DF® is a Bordetella bronchiseptica bacterin and a dermonecrotic toxin toxoid adjuvanted vaccine. It is used to control atrophic rhinitis in pigs by vaccinating breeding animals which will then pass on maternally derived antibodies. Target species Pigs (sows and gilts) Indications for use For the reduction of clinical signs of progressive atrophic rhinitis in piglets by passive oral immunisation with colostrum from dams actively immunised with the vaccine. Administer one dose of 2 ml by intramuscular injection to pigs of 18 weeks of age and older. The vaccine should preferably be administered just behind the ear. Vaccination scheme: Primary vaccination: inject one dose (2 ml) per pig, followed by a second injection 4 weeks after the first injection. The first injection should be administered 6 weeks before the expected date of farrowing. Revaccination: a single injection of one dose (2 ml) should be carried out 2 to 4 weeks prior to each subsequent farrowing. Withdrawal periods Pigs – meat 0 days

Porcilis Coliclos is a sow and gilt vaccine to protect against two of the most important pathogens for the development of neonatal diarrhoea, E. coli and C. perfringens. Target species Pigs (sows and gilts) Indications for use For the passive immunisation of progeny by active immunisation of sows and gilts to reduce mortality and clinical signs during the first days of life, caused by those E. coli strains, which express the adhesins F4ab (K88ab), F4ac (K88ac), F5 (K99) or F6 (987P) and caused by C. perfringens type C. Vaccination scheme: Primary vaccination: Sows/gilts which have not yet been vaccinated with the product are given a primary injection 6 to 8 weeks before the expected date of farrowing and a second injection 4 weeks later. Revaccination: A single revaccination is carried out 2 to 4 weeks before the expected date of farrowing. Intramuscular injection of 1 dose (2 ml) of vaccine per animal in the neck in the area behind the ear. Withdrawal periods Pigs – meat 0 days

Porcilis Ery is an inactivated vaccine containing Erysipelothrix rhusiopathiae strain M2 (serotype 2) for the active immunisation of sows, gilts and boars as an aid in the control of swine erysipelas.

Porcilis Ery+Parvo is an inactivated vaccine containing at least 1 ppd Erysipelothrix rhusiopathiae antigen and Porcine parvovirus (PPV) in an aqueous adjuvant. Target species Pigs (sows and gilts) Indications for use For the active immunisation of sows and gilts as an aid in the control of swine erysipelas and for the protection of embryos and foetuses against porcine parvovirus (PPV) infection. Withdrawal periods Pigs – meat 0 days

Erysipelas, parvovirosis and leptospirosis are widely spread infectious diseases that impact animal welfare and cause considerable losses to pig producers. Parvovirosis and leptospirosis are especially important for breeding units as they affect the sow fertility and development of pregnancy. Leptospirosis is also an important zoonosis so protecting the pig herds against it is crucial. Target species Pigs for reproduction – 2ml dose Indications for use For the active immunisation of pigs: - to reduce clinical signs (skin lesions and fever) of swine erysipelas caused by Erysipelothrix rhusiopathiae, serotype 1 and serotype 2. - to reduce transplacental infection, viral load and foetal mortality caused by Porcine parvovirus. - to reduce clinical signs (increase of body temperature and reduction in feed intake or activity), infection and bacterial excretion caused by L. interrogans serogroup Canicola serovar Canicola. - to reduce clinical signs (increase of body temperature and reduction in feed intake or activity), severity of infection and foetal mortality caused by L. interrogans serogroup Pomona serovar Pomona. - to reduce infection caused by L. interrogans serogroup Icterohaemorrhagiae serovars Copenhageni and Icterohaemorrhagiae, L. interrogans serogroup Australis serovar Bratislava, L. kirschneri serogroup Grippotyphosa serovars Grippotyphosa and Bananal/Liangguang, L. weilii serogroup Tarassovi serovar Vughia and L. borgpetersenii serogroup Tarassovi serovar Tarassovi. Withdrawal periods Meat 0 days

Erysipelas, parvovirosis and leptospirosis are widely spread infectious diseases that impact animal welfare and cause considerable losses to pig producers. Parvovirosis and leptospirosis are especially important for breeding units as they affect the sow fertility and development of pregnancy. Leptospirosis is also an important zoonosis so protecting the pig herds against it is crucial. Target species Pigs for reproduction – 2ml dose Indications for use For the active immunisation of pigs: - to reduce clinical signs (skin lesions and fever) of swine erysipelas caused by Erysipelothrix rhusiopathiae, serotype 1 and serotype 2. - to reduce transplacental infection, viral load and foetal mortality caused by Porcine parvovirus. - to reduce clinical signs (increase of body temperature and reduction in feed intake or activity), infection and bacterial excretion caused by L. interrogans serogroup Canicola serovar Canicola. - to reduce clinical signs (increase of body temperature and reduction in feed intake or activity), severity of infection and foetal mortality caused by L. interrogans serogroup Pomona serovar Pomona. - to reduce infection caused by L. interrogans serogroup Icterohaemorrhagiae serovars Copenhageni and Icterohaemorrhagiae, L. interrogans serogroup Australis serovar Bratislava, L. kirschneri serogroup Grippotyphosa serovars Grippotyphosa and Bananal/Liangguang, L. weilii serogroup Tarassovi serovar Vughia and L. borgpetersenii serogroup Tarassovi serovar Tarassovi. Withdrawal periods Meat 0 days

Porcilis Glasser is a vaccine used for active immunisation of pigs to reduce typical lesions of Glässer’s disease caused by Haemophilus parasuis serotype 5.The vaccine is of benefit when animals with no or low levels of antibodies against H. parasuis serotype 5 are mixed with pigs from or in an environment with a high prevalence of Glässer’s disease.

Porcine proliferative enteritis is a common diarrhoeal disease of growing-finishing and young breeding pigs characterized by hyperplasia and inflammation of the ileum and colon. Target species Pigs – 2ml dose Indications for use For the active immunisation of pigs from 3 weeks of age to reduce diarrhoea, loss of daily weight gain, intestinal lesions, bacterial shedding and mortality caused by Lawsonia intracellularis infection. Onset of immunity: 4 weeks after vaccination Duration of immunity: 21 weeks after vaccination Withdrawal period Meat 0 hours

Porcine proliferative enteritis is a common diarrhoeal disease of growing-finishing and young breeding pigs characterized by hyperplasia and inflammation of the ileum and colon. Target species Pigs – 2ml dose Indications for use For the active immunisation of pigs from 3 weeks of age to reduce diarrhoea, loss of daily weight gain, intestinal lesions, bacterial shedding and mortality caused by Lawsonia intracellularis infection. Onset of immunity: 4 weeks after vaccination Duration of immunity: 21 weeks after vaccination Withdrawal period Meat 0 hours